BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10460697)

  • 21. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
    Demant T; Gaw A; Watts GF; Durrington P; Buckley B; Imrie CW; Wilson C; Packard CJ; Shepherd J
    J Lipid Res; 1993 Jan; 34(1):147-56. PubMed ID: 8445339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fish oil supplementation on apolipoprotein B100 production and lipoprotein metabolism in normolipidaemic males.
    Bordin P; Bodamer OA; Venkatesan S; Gray RM; Bannister PA; Halliday D
    Eur J Clin Nutr; 1998 Feb; 52(2):104-9. PubMed ID: 9505154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.
    Abbott WG; Swinburn B; Ruotolo G; Hara H; Patti L; Harper I; Grundy SM; Howard BV
    J Clin Invest; 1990 Aug; 86(2):642-50. PubMed ID: 2200808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo studies of VLDL metabolism and LDL heterogeneity.
    Demant T; Packard C
    Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
    Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism.
    Packard CJ; Gaw A; Demant T; Shepherd J
    J Lipid Res; 1995 Jan; 36(1):172-87. PubMed ID: 7706942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.
    Ouguerram K; Zair Y; Billon S; Chétiveaux M; Brunet-François C; Ngohou-Bach K; Allavena C; Reliquet V; Milpied B; Magot T; Raffi F; Krempf M
    Med Chem; 2008 Nov; 4(6):544-50. PubMed ID: 18991738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men.
    Duvillard L; Florentin E; Lalanne-Mistrich ML; Petit JM; Baillot-Rudoni S; Brun-Pacaud A; Brun JM; Gambert P; Vergès B
    Diabetologia; 2005 Jul; 48(7):1366-72. PubMed ID: 15918022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension.
    Ikeda K; Suzuki M; Ikebuchi M; Hara Y; Tsushima M; Yamamoto A; Harano Y
    J Diabetes Complications; 1995; 9(4):227-9. PubMed ID: 8573733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compensatory mechanisms governing the concentration of plasma low density lipoprotein.
    Howard BV; Egusa G; Beltz WF; Kesäniemi YA; Grundy SM
    J Lipid Res; 1986 Jan; 27(1):11-20. PubMed ID: 3958608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein metabolism in subjects with hepatic lipase deficiency.
    Tilly-Kiesi M; Schaefer EJ; Knudsen P; Welty FK; Dolnikowski GG; Taskinen MR; Lichtenstein AH
    Metabolism; 2004 Apr; 53(4):520-5. PubMed ID: 15045702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G; Beltz WF; Grundy SM; Howard BV
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
    Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.
    Ooi EM; Russell BS; Olson E; Sun SZ; Diffenderfer MR; Lichtenstein AH; Keilson L; Barrett PH; Schaefer EJ; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):459-66. PubMed ID: 22095987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
    Arad Y; Ramakrishnan R; Ginsberg HN
    J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.